• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Psychiatry

Religiosity may be associated with abstinence in Latinx individuals with substance use disorders

byNicholas Ng Fat HingandAvneesh Bhangu
December 5, 2022
in Psychiatry, Public Health, Wellness
Reading Time: 2 mins read
Children’s hospital visits for suicide ideation and attempts are increasing
Share on FacebookShare on TwitterShare on LinkedIn

1. In this randomized controlled trial, participants had high scores for past-year religiosity and lifetime religiosity.

2. Furthermore, in the cognitive behavioral therapy (CBT) treatment group, religiosity was associated with a longer duration of abstinence

Evidence Rating Level: 2 (Good)

Latinx adults with substance use disorders are at high risk for dropout and often report treatment dissatisfaction. Spirituality and religion have been identified as factors related to substance use treatment outcomes; however, they have rarely been studied among Latinx populations. As a result, the objective of the present study was to assess the relationship between past-year religiosity scores and treatment outcomes in the full sample, while also exploring differences in baseline characteristics and treatment outcomes across subgroups.

The parent randomized controlled trial (RCT) described elsewhere included 92 participants from 3 outpatient clinics offering substance use treatment for Spanish-speakers in the United States. Participants were included if their primary language was Spanish, met current substance use criteria, and used substances within 28 days of the screening date. Participants were excluded if they were not sufficiently stable for 8 weeks of outpatient follow-up. The standard treatment group received usual substance use treatment whereas the treatment group included access to a culturally adapted CBT program (CBT4CBT-Spanish). Religiosity was measured at baseline using The Religious Background and Behavior (RBB) questionnaire. Similarly, daily substance use was assessed using the calendar-based Timeline Follow Back. Data was analyzed using two-tailed tests.

Results demonstrated that religiosity in the past year was positively associated with one measure of abstinence for those randomized to CBT4CBT-Spanish; however, this did not persist during a six-month follow-up period. Furthermore, in Latinx adults receiving a culturally adapted cognitive behavioral therapy treatment, religiosity may be associated with longer duration of abstinence. Despite these findings, the study was limited by the fact that the parent RCT was not designed to test religiosity or spirituality on outcomes. Nonetheless, the study had excellent follow-up rates and data availability which strengthen its results.

RELATED REPORTS

Children with intellectual and developmental disabilities have increased risks of depression and anxiety

Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms

Click to read the study in Journal of Religion and Health 

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: abstinenceanxietyCBTcognitive behavioral therapydepressionLatinxsubstance usesubstance use disorderSUDwellness
Previous Post

Autoimmune encephalitis misdiagnosis in adults can lead to harm

Next Post

Preclinical detectable phase for open-angle glaucoma estimated at 10 years

RelatedReports

A young boy studying at a desk with books and a contrasting image of an adult man walking outdoors, symbolizing the life course from childhood to adulthood.
Pediatrics

Children with intellectual and developmental disabilities have increased risks of depression and anxiety

October 14, 2026
A man sits pensively by a window with a depiction of a synapse illustrating neurotransmitter activity, suggesting a focus on mental health treatment mechanisms.
Artificial Intelligence

Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms

September 11, 2026
Quick Take: Prevalence and Treatment of Depression, Anxiety, and Conduct Problems in US Children
Chronic Disease

Positive psychotherapy may be similarly effective to traditional cognitive behavioural therapy for panic disorder

August 21, 2026
Chronic Disease

Behavioral support does not improve patient-directed opioid tapering success

July 6, 2026
Next Post
Roux-en-Y gastric bypass may slow progression of diabetic retinopathy

Preclinical detectable phase for open-angle glaucoma estimated at 10 years

Complement mutation linked to poor response to eculizumab

Overall survival with triplet therapy in BRAF V600 mutation-positive advanced melanoma

Patient Basics: Brain Tumor Overview

Autologous tumour lysate-loaded dendritic cell vaccine in conjunction with standard treatment for glioblastoma may increase overall survival

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Optogenetic therapy may partially restore vision in retinitis pigmentosa
  • An artificial intelligence system for human papillomavirus-positive dual stain cervical cancer screening reads p16-Ki67 slides
  • Elevated low-density lipoprotein cholesterol is a risk factor for atherosclerotic disease irrespective of familial hypercholesterolemia status
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.